Pharmaceuticals
The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know
more?
You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.
The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health.
Show Less
Read more
Hill-Rom Company, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Knopp NeuroSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Protea Biosciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Fibrocell Science, Inc. (formerly Isolagen, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
GenoLogics Life Sciences Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Signum Biosciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
BioMimetic Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
GeoVax Labs, Inc. (formerly Dauphin Technology, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Eleme Medical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Metagenics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
IMAXIO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Aushon BioSystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Patrys Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
LifeSensors, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Bucher Biotec AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Orthovita, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
CyDex Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Collegium Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Pevion Biotech, AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
Enzon Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:
Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...
November
2012
FROM
EUR 268USD 350GBP 226AUD 372JPY 34,277SEK 2 318CHF 329CAD 364
